SYNCOM FORMULATIONS Fact Sheet, SYNCOM FORMULATIONS Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SYNCOM FORMULATIONS Fact Sheet    (SFRM)


EV Stocks: A Hidden Way to Tap into the Massive 15x EV Opportunity


Here is the latest financial fact sheet of SYNCOM FORMULATIONS. For more details, see the SYNCOM FORMULATIONS quarterly results and SYNCOM FORMULATIONS share price and chart. For a sector overview, read our pharmaceuticals sector report.

SYNCOM FORMULATIONS Price History

Price Rs 10.6
Mkt Cap Rs m 8,334
Vol '000 3,276.1
P/E X 26.4
P/CF X 25.1
EPS (TTM) Rs 0.4
% ch % 2.3
No. of shares m 789.95
% ch week % 5.6
% ch 1-mth % 66.1
% ch 12-mth % 659.0
52 week H/L Rs 13.6/1.4
(As on Oct 21, 2021 (Close))
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

SYNCOM FORMULATIONS Financials

No. of Mths
Year Ending
12
Mar-17
*
12
Mar-18
*
12
Mar-19
*
12
Mar-20
*
12
Mar-21
*
5-Yr Chart
Click to enlarge
SYNCOM FORMULATIONS EQUITY SHARE DATA
High Rs33214 
Low Rs211NA1 
Sales per share (Unadj.) Rs2.42.02.42.63.1 
Earnings per share (Unadj.) Rs0.10.10.10.20.4 
Diluted earnings per shareRs0.10.10.10.20.4 
Cash flow per share (Unadj.) Rs0.20.20.20.20.4 
Dividends per share (Unadj.) Rs0.020000 
Adj. dividends per shareRs0.020.000.000.000.00 
Avg Dividend yield %0.80000 
Book value per share (Unadj.) Rs1.51.61.71.92.3 
Adj. book value per shareRs1.51.51.71.82.3 
Shares outstanding (eoy) m780.65780.65780.65780.65789.95 
Bonus / Rights / Conversions  ----- 
Price / Sales ratio x1.10.90.50.30.7 
Avg P/E ratio x19.715.77.94.46.3 
P/CF ratio (eoy) x15.210.95.83.45.5 
Price / Book Value ratio x1.81.10.70.41.0 
Dividend payout %14.80000 
Avg Mkt Cap Rs m2,0771,3548746251,833 
No. of employees `000NANANANANA 
Total wages/salary Rs m145148152158183 
Avg. sales/employee Rs ThNMNMNMNMNM 
Avg. wages/employee Rs ThNMNMNMNMNM 
Avg. net profit/employee Rs ThNMNMNMNMNM 
SYNCOM FORMULATIONS INCOME DATA
Net Sales Rs m1,8481,5851,8682,0552,448 
Other income Rs m2844515271 
Total revenues Rs m1,8761,6301,9192,1072,519 
Gross profit Rs m165116118167380 
Depreciation Rs m3137404140 
Interest Rs m33264 
Profit before tax Rs m159120127173407 
Minority Interest Rs m00000 
Prior Period Items Rs m00000 
Extraordinary Inc (Exp) Rs m00000 
Tax Rs m53341630115 
Profit after tax Rs m10586111143292 
Gross profit margin %9.07.36.38.115.5 
Effective tax rate %33.728.012.517.628.3 
Net profit margin %5.75.55.96.911.9 
SYNCOM FORMULATIONS BALANCE SHEET DATA
Current assets Rs m8658148138941,996 
Current liabilities Rs m5884273583121,065 
Net working cap to sales %15.024.424.428.338.0 
Current ratio x1.51.92.32.91.9 
Inventory Days Days83799186100 
Debtors Days Days91878176,978,436111,558,597 
Net fixed assets Rs m9749269479451,018 
Share capital Rs m781781781781790 
"Free" reserves Rs m393439546676988 
Net worth Rs m1,1741,2191,3261,4571,778 
Long term debt Rs m00000 
Total assets Rs m1,8391,7401,7601,8393,014 
Interest coverage x48.541.552.529.2105.4 
Debt to equity ratio x00000 
Sales to assets ratio x1.00.91.11.10.8 
Return on assets %5.95.16.48.19.8 
Return on equity %9.07.18.49.816.4 
Return on capital %13.810.19.712.323.1 
Exports to sales %73.877.860.459.869.7 
Imports to sales %00.30.10.60.2 
Exports (fob) Rs m1,3641,2341,1271,2291,707 
Imports (cif) Rs m052124 
Fx inflow Rs m1,3641,2341,1271,2291,707 
Fx outflow Rs m883144 
Net fx Rs m1,3561,2261,1241,2151,704 
SYNCOM FORMULATIONS CASH FLOW
From Operations Rs m 138 -16 43 59 -20 
From Investments Rs m -177 -22 24 15 -727 
From Financial Activity Rs m 47 -20 -2 -65 720 
Net Cashflow Rs m 8 -58 66 9 -27 
* Results Consolidated
Source: Accord Fintech, Equitymaster

Share Holding

Promoters 41.2%
Institution 0.0%
Non-Institution 58.8%
Total 100.0%
Free Float 58.8%
Pledged promoter holdings 0.0%
 

Company Information

REGD OFF 7 Niraj Industrial Estate, Off Mahakali Caves Road, Andheri (E), Mumbai - 400093
E-MAIL sfil87@hotmail.com WEB www.sfil.in
TEL 022 30887744-54 FAX 022 30887755
SECTOR PHARMACEUTICALS GROUP Private sector
TR AGENT Ankit Consultancy Pvt Ltd, Plot No 60, Electronic Complex, Pardeshipura
YEAR OF INC: 1988 BSE CODE: 524470 FV (Rs): 1 DIV YIELD (%): -

More Pharmaceuticals Company Fact Sheets:   MERCURY LAB.  ARTEMIS MEDICARE SERVICES  SWAGRUHA INFRA  DHANVANTRI JEEV  ANG LIFESCIENCES INDIA  

Compare SYNCOM FORMULATIONS With:   MERCURY LAB.  ARTEMIS MEDICARE SERVICES  SWAGRUHA INFRA  DHANVANTRI JEEV  ANG LIFESCIENCES INDIA  




Today's Market

Sensex Ends 336 Points Lower, Nifty Falls Below 18,200; Asian Paints Tanks 5%(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended lower.

Views on news

Demerger of Financial & Pharma Businesses puts Piramal Enterprises in Limelight (Views On News)

Oct 8, 2021

The company's shareholders will be issued 4 shares in the demerged entity for every 1 held in Piramal Enterprises.

Block Deal Disappoints Max Healthcare Shareholders. Stock Falls 6% (Views On News)

Sep 30, 2021

The divestment of 6.6% stake by the promoter is considered to be one of the largest block deals of the market.

5 Indian Pharma Companies Riding the Vaccination Wave (Views On News)

Sep 3, 2021

These companies are likely to benefit the most from Covid-19 vaccines.

Apollo Hospitals' Shares Rally Over 5%, Hit Record-High on Strong Results (Views On News)

Aug 16, 2021

The company reported a 73% YoY increase in revenue driven by an uptick in the hospital and pharmacy business.

J B Chemicals & Pharma's Decent Performance Puts Stock in Focus (Views On News)

Aug 13, 2021

The company seeks to expand the market for prescription lozenges with new launches this year.

More Views on News

Most Popular

Is it Time to Switch from Tata Power to NTPC? (Profit Hunter)

Oct 11, 2021

Given the huge run up in Tata Power, does it make sense to switch to NTPC?

This Proxy EV Stock Just got a Power Crisis Boost (Profit Hunter)

Oct 8, 2021

After months of research, I've come across few stocks that excite me far more than the mainstream electric vehicle companies.

Rs 1 Lakh Invested in These Cryptos at the Start of 2021 Became Rs... (Views On News)

Oct 8, 2021

These cryptos would have multiplied investors' wealth by as much as 10,000% in just nine months.

Modi's Big Move Could Boost these 5 Defence Stocks (Views On News)

Oct 11, 2021

To corporatise the defence sector, the Ministry of Defence (MoD) has dissolved the 250-year-old Ordnance Factory Board (OFB).

5 Green Energy Stocks to Watch as India Readies for a Revolution (Views On News)

Oct 13, 2021

The excitement around green energy stocks has opened up a huge contrarian opportunity in the traditional energy space.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TRACK SYNCOM FORMULATIONS

  • Track your investment in SYNCOM FORMULATIONS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON SYNCOM FORMULATIONS

SYNCOM FORMULATIONS - ACTAVIS COMPARISON

COMPARE SYNCOM FORMULATIONS WITH

MARKET STATS